Assignee
ADVERIO PHARMA GMBH
DE·19 granted patents·4 pending applications·40 citations·filing 2014–2024
Top patents by PatentIndex Score
23 records- 0196US9993476B2Substituted 5-flouro-1H-pyrazolopyridines and their useADVERIO PHARMA GMBH·Filed 2016·Granted Jun 12, 2018·16 cites·13 claims
- 0295US11439642B2Substituted 5-fluoro-1H-pyrazolopyridines and their useADVERIO PHARMA GMBH·Filed 2020·Granted Sep 13, 2022·3 cites·66 claims
- 0393US9604948B2Process for preparing substituted 5-fluoro-1H-pyrazolopyridinesADVERIO PHARMA GMBH·Filed 2015·Granted Mar 28, 2017·5 cites·8 claims
- 0491US11203593B2Forms of methyl {4,6-diamino-2-[1(2-fluorobenzyl)-1H-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamateADVERIO PHARMA GMBH·Filed 2020·Granted Dec 21, 2021·2 cites·22 claims
- 0590US9845300B2Process for preparing substituted 5-fluoro-1H-pyrazolopyridinesADVERIO PHARMA GMBH·Filed 2017·Granted Dec 19, 2017·3 cites·1 claims
- 0689US10736896B2Substituted 5-fluoro-1H-pyrazolopyridines and their useADVERIO PHARMA GMBH·Filed 2018·Granted Aug 11, 2020·2 cites·7 claims
- 0789US10351562B2Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-B]pyridin-3-yl]pyrimidin-5-yl}methylcarbamate and its purification for use as pharmaceutically active compoundADVERIO PHARMA GMBH·Filed 2018·Granted Jul 16, 2019·6 cites·9 claims
- 0886US12064429B2Substituted 5-fluoro-1H-pyrazolopyridines and their useADVERIO PHARMA GMBH·Filed 2022·Granted Aug 20, 2024·0 cites·18 claims
- 0980US10633356B2Hydrates of substituted 5-fluoro-1H-pyrazolopyridinesADVERIO PHARMA GMBH·Filed 2019·Granted Apr 28, 2020·0 cites·12 claims
- 1079US12503469B2Forms of methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl} methyl carbamateADVERIO PHARMA GMBH·Filed 2021·Granted Dec 23, 2025·0 cites·5 claims
- 1178US10030014B2Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}methylcarbamate and its purification for use as pharmaceutically active compoundADVERIO PHARMA GMBH·Filed 2014·Granted Jul 24, 2018·2 cites·5 claims
- 1277US10087183B2Forms of methyl {4,6-diamino-2-[1 (2-fluorobenzyl)-1h-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamateADVERIO PHARMA GMBH·Filed 2017·Granted Oct 2, 2018·1 cites·30 claims
- 1371US10633357B2Intermediates and process for preparing intermediates in the production of substituted pyrazolopyridinesADVERIO PHARMA GMBH·Filed 2019·Granted Apr 28, 2020·0 cites·3 claims
- 1470US2025205235A1Dose regimen for vericiguatADVERIO PHARMA GMBH·Filed 2024·Application pending·0 cites
- 1569US10570130B2Process for preparing methyl{4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}methylcarbamate and its purification for use as pharmaceutically active compoundADVERIO PHARMA GMBH·Filed 2019·Granted Feb 25, 2020·0 cites·2 claims
- 1669US10364229B2Crystalline substituted 5-fluoro-1H-pyrazolopyridines and process for preparingADVERIO PHARMA GMBH·Filed 2017·Granted Jul 30, 2019·0 cites·3 claims
- 1766US10662188B2Forms of methyl {4,6-diamino-2-[1 (2-fluorobenzyl)-1H-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl} methyl carbamateADVERIO PHARMA GMBH·Filed 2018·Granted May 26, 2020·0 cites·30 claims
- 1860US2016129004A1Substituted 5-fluoro-1h-pyrazolopyridines and their useADVERIO PHARMA GMBH·Filed 2016·Application pending·0 cites
- 1947US11508483B2Method of identifying a subgroup of patients suffering from dcSSc which benefits from a treatment with sGC stimulators and sGC activators in a higher degree than a control groupADVERIO PHARMA GMBH·Filed 2019·Granted Nov 22, 2022·0 cites·10 claims
- 2046US2023219952A1Process for preparing methyl {4,6-diamino-2-[5-fluoro-1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3 -yl]pyrimidin-5-yl} carbamateADVERIO PHARMA GMBH·Filed 2021·Application pending·0 cites
- 2145US11760737B2Process for manufacturing 4-(2,2,3,3-tetrafluoropropyl)morpholineADVERIO PHARMA GMBH·Filed 2020·Granted Sep 19, 2023·0 cites·10 claims
- 2242US2023067593A1Nanoformulations of methyl {4,6-diamino-2-[5-fluoro-1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3 -yl]pyrimidin-5-yl} carbamateADVERIO PHARMA GMBH·Filed 2021·Application pending·0 cites
- 2338US12172996B2Methyl {4,6-diamino-2-[5-fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}carbamate active compound product having improved properties, production and formulation thereofADVERIO PHARMA GMBH·Filed 2019·Granted Dec 24, 2024·0 cites·13 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →